Skip Main Navigation
Page Content
This event has ended

Save This Event

Event Saved

CTAC Patient Group Input Webinar: Ombitasvir/Paritaprevir/Ritonavir


Monday, 21 September 2015 from 11:00 AM to 12:00 PM (EDT)

Registration Information

Type End Quantity
PGI virtual attendee   more info Ended Free  

Event Details

Please join CTAC Policy Researcher Adam Cook for an informative webinar detailing an exciting new HCV treatment, Ombitasvir/Paritaprevir/ritonavir. Currently undergoing review by the Common Drug Review, this treatment is intended to treat chronic HCV, genotype 4. 

Presenter Bio

Adam Cook is CTAC’s Policy Researcher specializing in HCV, regulatory affairs, and treatment development. 

Have questions about CTAC Patient Group Input Webinar: Ombitasvir/Paritaprevir/Ritonavir? Contact CTAC


Monday, 21 September 2015 from 11:00 AM to 12:00 PM (EDT)

  Add to my calendar



CTAC is Canada’s non-governmental organization led by and for people living with HIV and HIV/HCV co-infection, focusing on access to treatment. Since 1996, we have been working to secure and ensure equitable, affordable and timely access to treatment, care and support for people in Canada living with HIV and HIV/HCV co-infection. We work with community, public, private and not-for-profit leaders to inform research and public policy, and promote public awareness and discussion. 

  Contact the Organizer

Interested in hosting your own event?

Join millions of people on Eventbrite.

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.